Katie Kalvaitis

In patients with HF and secondary mitral regurgitation, transcatheter edge-to-edge repair was noninferior to mitral valve surgery for efficacy and was linked with fewer safety endpoint events, according to data from the MATTERHORN trial. MATTERHORN, presented at the European Society of Cardiology Congress and simultaneously published in The New England Journal of Medicine, was an

A single combined measure of three modifiable biomarkers in healthy women at midlife was predictive of 30-year risk for future cardiovascular events, according to new research presented at the European Society of Cardiology Congress.

In patients with coronary artery disease and severe aortic stenosis undergoing transcatheter aortic valve replacement, those who also had PCI had better outcomes than those who had their CAD managed conservatively, researchers reported. The investigator-initiated NOTI3 trial, presented at the European Society of Cardiology Congress and simultaneously published in The New England Journal of

Key takeaways: The Menopause Society launched a new monthly series to address gaps in menopause education.

CHICAGO — Hormone therapy is beneficial for some women beyond age 65 years to treat ongoing menopausal symptoms that affect their quality of life, according to research reported at the Annual Meeting of The Menopause Society.

CHICAGO — Voice and respiratory changes can impact women’s health during menopause and hormone therapy plays a role in helping or worsening these changes, according to a speaker at the Annual Meeting of The Menopause Society. Voice and speech contain important biomarkers that can give insight on women's health related to hormonal changes,” Yael Bensoussan, MD, MSC, assistant

CHICAGO — The benefits of AI-assisted technology in medicine are rapidly extending to obstetrics and gynecology, with programs in development or already deployed to predict everything from mode of delivery during labor to cervical cancer risk.

For older adults with non-STEMI, routine coronary intervention was safe but did not lower risk for death from CV causes or nonfatal MI compared with medical therapy alone, according to new data from the SENIOR-RITA trial.“Our study, in a sense, provides a foundation for older heart attack patients and their clinicians to make informed decisions about whether they need to undergo invasive

CHICAGO — Hormone therapy use among menopausal women has fallen to just 1.8% as of 2023, data show, despite evidence and clinical guidance suggesting HT is safe and effective for most women for bothersome menopausal symptoms.

CHICAGO — Busy women physicians have much to gain by seeking out small moments of self-care, reflecting on ways to make positive change and sharing their personal stories with other women to build a more connected community.